These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2961401)

  • 1. Gonadotrophin hormone releasing analogues open new doors in cancer treatment.
    Waxman J
    Br Med J (Clin Res Ed); 1987 Oct; 295(6606):1084-5. PubMed ID: 2961401
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of carcinoma of the prostate with analogs of LHRH].
    Rubio Herrera MA; Calle Fernández JR
    Rev Clin Esp; 1986 Nov; 179(8):407-11. PubMed ID: 2951782
    [No Abstract]   [Full Text] [Related]  

  • 3. Metastatic carcinoma of the prostate in both testes of patients treated with LH-RH analogues.
    Hadjissotiriou GG; Papadopoulos S; Rebelakos A
    Br J Urol; 1992 Jun; 69(6):657-9. PubMed ID: 1386273
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to D-Trp-6-luteinising hormone releasing hormone (Decapeptyl) microcapsules in advanced ovarian cancer.
    Parmar H; Rustin G; Lightman SL; Phillips RH; Hanham IW; Schally AV
    Br Med J (Clin Res Ed); 1988 Apr; 296(6631):1229. PubMed ID: 2968130
    [No Abstract]   [Full Text] [Related]  

  • 5. Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer.
    Waxman J; Man A; Hendry WF; Whitfield HN; Besser GM; Tiptaft RC; Paris AM; Oliver RT
    Br Med J (Clin Res Ed); 1985 Nov; 291(6506):1387-8. PubMed ID: 2933122
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical or surgical orchidectomy.
    Parmar H; Edwards LE; Phillips RH; Charlton C; Lightman SI
    BMJ; 1991 May; 302(6787):1272. PubMed ID: 1828382
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical progress with LHRH analogues in prostatic cancer. Proceedings of an international symposium. Monte Carlo, 20 January 1990.
    J Int Med Res; 1990; 18 Suppl 1():1-125. PubMed ID: 2108881
    [No Abstract]   [Full Text] [Related]  

  • 8. Gonadotropin-releasing hormone analogs and prostatic cancer.
    Swanson LJ; Seely JH; Garnick MB
    Crit Rev Oncol Hematol; 1988; 8(1):1-26. PubMed ID: 2964939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease flare induced by luteinising hormone releasing hormone analogues in cancer patients.
    Deghenghi R; Misset JL
    Lancet; 1984 Jun; 1(8389):1302. PubMed ID: 6145013
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-tumor effects of GnRH analogs in gynecological cancers].
    Yano T; Taketani Y
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():127-31. PubMed ID: 16689297
    [No Abstract]   [Full Text] [Related]  

  • 11. New gonadotropin-releasing hormone glycolipids with direct antiproliferative activity and gonadotropin-releasing potency.
    Varamini P; Mansfeld FM; Giddam AK; Steyn F; Toth I
    Int J Pharm; 2017 Apr; 521(1-2):327-336. PubMed ID: 28232269
    [No Abstract]   [Full Text] [Related]  

  • 12. LH-RH agonist monotherapy in patients with carcinoma of the prostate and reflections on the so-called total androgen blockade.
    Jacobi GH
    Recent Results Cancer Res; 1990; 118():174-85. PubMed ID: 2146724
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of metastatic carcinoma of the prostate with leuprolide, an LHRH analogue.
    Smith JA
    Prog Clin Biol Res; 1985; 185A():279-85. PubMed ID: 3929267
    [No Abstract]   [Full Text] [Related]  

  • 14. New prostate cancer drugs: few CV effects?
    Henahan J
    JAMA; 1983 Oct; 250(16):2097-9. PubMed ID: 6413706
    [No Abstract]   [Full Text] [Related]  

  • 15. Leuprolide: a review of its effects in comparison with diethylstilboestrol in the treatment of advanced cancer of the prostate.
    Garnick MB; Glode LM; Smith JA; Max DT
    Br J Clin Pract; 1985 Feb; 39(2):73-6. PubMed ID: 3921047
    [No Abstract]   [Full Text] [Related]  

  • 16. Androgen suppression by a gonadotropin releasing hormone analogue in patients with metastatic carcinoma of the prostate.
    Smith JA
    J Urol; 1984 Jun; 131(6):1110-2. PubMed ID: 6427478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal therapy for prostate cancer.
    Torti FM
    N Engl J Med; 1984 Nov; 311(20):1313-4. PubMed ID: 6436701
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined androgen blockade: leuprolide and flutamide versus leuprolide and placebo.
    Crawford ED; Goodman P; Blumenstein B
    Semin Urol; 1990 Aug; 8(3):154-8. PubMed ID: 2119048
    [No Abstract]   [Full Text] [Related]  

  • 19. Direct antitumor effects of LH-RH analogs.
    Foekens JA; Klijn JG
    Recent Results Cancer Res; 1992; 124():7-17. PubMed ID: 1615221
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dramatic aggravation of prostatic cancer at the onset of treatment with an LHRH agonist].
    Boumier P; Koeger AC; Camus JP
    Presse Med; 1985 May; 14(21):1200-1. PubMed ID: 3158996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.